Estimated timeline and details on public availability of Novavax
Mr Massey made this Official Information request to Ministry of Health
The request was successful.
From: Mr Massey
Dear Ministry of Health,
I'd like to inquire as to the current status of Novavax (Nuvaxoid) in regards to it's availability for actual use as a primary vaccination against Covid-19.
In addition, I'd also like information on the current status of it's delivery to New Zealand. According to Reuters (https://www.reuters.com/business/healthc...) New Zealand apparently received a shipment on Monday, 7th of February
Yours faithfully, Mr Massey
From: OIA Requests
Thank you for your Official Information Act request. This is
an automatic reply to let you know we received it.
In accordance with the Act, we'll let you know our decision within no more
than 20 working days. If you'd like to calculate the timeframe, you can
use the Ombudsman's online calculator
here: [1]http://www.ombudsman.parliament.nz/
Due to the COVID-19 global pandemic response, the Ministry is experiencing
significantly higher volumes of queries and requests for information. This
means we may take some time in responding to your request. The Ministry
regularly updates information about the COVID-19 situation and publishes
OIA responses considered to be of public interest:
[2]https://www.health.govt.nz/about-ministr...
Please also refer to the Unite Against Covid-19 website for copies of
papers, minutes, and key advice for the decisions the Government has made
relating to COVID-19.
Sometimes we may need to clarify aspects of a request. You can expect to
hear from us soon if that is the case here.
Ngā mihi,
OIA Services
Government Services
Office of the Director-General
Ministry of Health
E: [3][email address]
****************************************************************************
Statement of confidentiality: This e-mail message and any accompanying
attachments may contain information that is IN-CONFIDENCE and subject to
legal privilege.
If you are not the intended recipient, do not read, use, disseminate,
distribute or copy this message or attachments.
If you have received this message in error, please notify the sender
immediately and delete this message.
****************************************************************************
--------------------------------------------------------------------------
This e-mail message has been scanned for Viruses and Content and cleared
by the Ministry of Health's Content and Virus Filtering Gateway
--------------------------------------------------------------------------
References
Visible links
1. http://scanmail.trustwave.com/?c=15517&a...
2. https://www.health.govt.nz/about-ministr...
3. mailto:[email address]
hide quoted sections
From: OIA Requests
Kia ora Mr Massey,
Thank you for your email. You asked:
The current status of Novavax (Nuvaxoid) in regards to it's availability
for actual use as a primary vaccination against Covid-19.
In addition, I'd also like information on the current status of it's
delivery to New Zealand. According to Reuters. New Zealand apparently
received a shipment on Monday, 7th of February
On the 4th of February 2022, New Zealand medicines regulator Medsafe has
granted provisional approval of the Novavax COVID-19 vaccine for adults 18
years and over.
Medsafe’s provisional approval is only one step of the process. Ministers
will have to consider advice from the Ministry of Health and the COVID-19
Vaccine Technical Advisory Group (CV-TAG) about whether to use the Novavax
vaccine in New Zealand. Following CV-TAG advice and pending Cabinet’s
decision to use, officials are working with Novavax to establish delivery
options as early as Q1 2022
At this time, we are unable to provide you with an expected timeframe for
the use of the Novavax vaccine in New Zealand.
Under section 28(3) of the Act you have the right to ask the Ombudsman to
review any decisions made under this request. The Ombudsman may be
contacted by email at: [1][email address] or by calling 0800
802 602.
Ngâ mihi
OIA Services Team
[2]Ministry of Health information releases
[3]Unite against COVID-19
--------------------------------------------------------------------------
From: Mr Massey <[FOI #18521 email]>
Sent: Thursday, 10 February 2022 19:39
To: OIA Requests <[email address]>
Subject: Official Information request - Estimated timeline and details on
public availability of Novavax
Dear Ministry of Health,
I'd like to inquire as to the current status of Novavax (Nuvaxoid) in
regards to it's availability for actual use as a primary vaccination
against Covid-19.
In addition, I'd also like information on the current status of it's
delivery to New Zealand. According to Reuters
([4]https://scanmail.trustwave.com/?c=15517&...)
New Zealand apparently received a shipment on Monday, 7th of February
Yours faithfully, Mr Massey
-------------------------------------------------------------------
This is an Official Information request made via the FYI website.
Please use this email address for all replies to this request:
[FOI #18521 email]
Is [Ministry of Health request email] the wrong address for Official Information requests
to Ministry of Health? If so, please contact us using this form:
[5]https://scanmail.trustwave.com/?c=15517&...
Disclaimer: This message and any reply that you make will be published on
the internet. Our privacy and copyright policies:
[6]https://scanmail.trustwave.com/?c=15517&...
If you find this service useful as an Official Information officer, please
ask your web manager to link to us from your organisation's OIA or LGOIMA
page.
-------------------------------------------------------------------
****************************************************************************
Statement of confidentiality: This e-mail message and any accompanying
attachments may contain information that is IN-CONFIDENCE and subject to
legal privilege.
If you are not the intended recipient, do not read, use, disseminate,
distribute or copy this message or attachments.
If you have received this message in error, please notify the sender
immediately and delete this message.
****************************************************************************
--------------------------------------------------------------------------
This e-mail message has been scanned for Viruses and Content and cleared
by the Ministry of Health's Content and Virus Filtering Gateway
--------------------------------------------------------------------------
References
Visible links
1. mailto:[email address]
2. https://www.health.govt.nz/about-ministr...
3. https://covid19.govt.nz/
4. https://scanmail.trustwave.com/?c=15517&...
5. https://scanmail.trustwave.com/?c=15517&...
6. https://scanmail.trustwave.com/?c=15517&...
hide quoted sections
From: Mr Massey
Dear OIA Requests,
You do not appear to have even attempted to answer my question, and have instead responded with a boiler plate response that is already present on the MoH site. To clarify, I have the following requests;
- The advice that the Ministry of Health and the CVTAG has provided as to the use of Novavax
- Information as to the supposed delivery of Nuvaxoid on Monday, 7th of February.
If the MoH is not the relevant ministry for this request, please inform me as to where I should direct my inquiry.
Yours sincerely,
Mr Massey
From: OIA Requests
Kia ora Mr Massey,
Thank you for your request for official information. The Ministry's
reference number for your request is: H202201291.
As required under the Official Information Act 1982, the Ministry will
endeavour to respond to your request no later than 20 working days after
the day your request was received. If you'd like to calculate the
timeframe, you can use the Ombudsman's online calculator
here: [1]http://www.ombudsman.parliament.nz/
Due to the COVID-19 global pandemic response, the Ministry is experiencing
significantly higher volumes of queries and requests for information. If
we are unable to respond to your request within this time frame, we will
notify you of an extension of that time frame.
If you have any queries related to this request, please do not hesitate to
get in touch.
Ngā mihi
OIA Services
Government Services
Office of the Director-General
Ministry of Health
E: [2][email address]
-----Original Message-----
From: Mr Massey <[FOI #18521 email]>
Sent: Friday, 11 February 2022 6:46 pm
To: OIA Requests <[email address]>
Subject: Re: Response to your correspondence 10 February 2022
Dear OIA Requests,
You do not appear to have even attempted to answer my question, and have
instead responded with a boiler plate response that is already present on
the MoH site. To clarify, I have the following requests;
- The advice that the Ministry of Health and the CVTAG has provided as to
the use of Novavax
- Information as to the supposed delivery of Nuvaxoid on Monday, 7th of
February.
If the MoH is not the relevant ministry for this request, please inform me
as to where I should direct my inquiry.
Yours sincerely,
Mr Massey
-----Original Message-----
Kia ora Mr Massey,
Thank you for your email. You asked:
The current status of Novavax (Nuvaxoid) in regards to it's availability
for actual use as a primary vaccination against Covid-19.
In addition, I'd also like information on the current status of it's
delivery to New Zealand. According to Reuters. New Zealand apparently
received a shipment on Monday, 7th of February
On the 4th of February 2022, New Zealand medicines regulator Medsafe has
granted provisional approval of the Novavax COVID-19 vaccine for adults
18 years and over.
Medsafe’s provisional approval is only one step of the process. Ministers
will have to consider advice from the Ministry of Health and the COVID-19
Vaccine Technical Advisory Group (CV-TAG) about whether to use the
Novavax vaccine in New Zealand. Following CV-TAG advice and pending
Cabinet’s decision to use, officials are working with Novavax to
establish delivery options as early as Q1 2022
At this time, we are unable to provide you with an expected timeframe for
the use of the Novavax vaccine in New Zealand.
Under section 28(3) of the Act you have the right to ask the Ombudsman to
review any decisions made under this request. The Ombudsman may be
contacted by email at: [1][email address] or by calling 0800
802 602.
Ngâ mihi
OIA Services Team
[2]Ministry of Health information releases
[3]Unite against COVID-19
--------------------------------------------------------------------------
From: Mr Massey <[FOI #18521 email]>
Sent: Thursday, 10 February 2022 19:39
To: OIA Requests <[email address]>
Subject: Official Information request - Estimated timeline and details on
public availability of Novavax
Dear Ministry of Health,
I'd like to inquire as to the current status of Novavax (Nuvaxoid) in
regards to it's availability for actual use as a primary vaccination
against Covid-19.
In addition, I'd also like information on the current status of it's
delivery to New Zealand. According to Reuters
([4][3]https://scanmail.trustwave.com/?c=15517&...)
New Zealand apparently received a shipment on Monday, 7th of February
Yours faithfully, Mr Massey
-------------------------------------------------------------------
This is an Official Information request made via the FYI website.
Please use this email address for all replies to this request:
[FOI #18521 email]
Is [Ministry of Health request email] the wrong address for Official
Information requests to Ministry of Health? If so, please contact us
using this form:
[5][4]https://scanmail.trustwave.com/?c=15517&...
Disclaimer: This message and any reply that you make will be published on
the internet. Our privacy and copyright policies:
[6][5]https://scanmail.trustwave.com/?c=15517&...
If you find this service useful as an Official Information officer,
please ask your web manager to link to us from your organisation's OIA or
LGOIMA page.
This e-mail message has been scanned for Viruses and Content and cleared
by the Ministry of Health's Content and Virus Filtering Gateway
--------------------------------------------------------------------------
References
Visible links
1. [6]mailto:[email address]
2. [7]https://www.health.govt.nz/about-ministr...
3.
[8]https://scanmail.trustwave.com/?c=15517&...
4.
[9]https://scanmail.trustwave.com/?c=15517&...
5.
[10]https://scanmail.trustwave.com/?c=15517&...
6.
[11]https://scanmail.trustwave.com/?c=15517&...
-------------------------------------------------------------------
Please use this email address for all replies to this request:
[12][FOI #18521 email]
Disclaimer: This message and any reply that you make will be published on
the internet. Our privacy and copyright policies:
[13]https://scanmail.trustwave.com/?c=15517&...
If you find this service useful as an Official Information officer, please
ask your web manager to link to us from your organisation's OIA or LGOIMA
page.
-------------------------------------------------------------------
****************************************************************************
Statement of confidentiality: This e-mail message and any accompanying
attachments may contain information that is IN-CONFIDENCE and subject to
legal privilege.
If you are not the intended recipient, do not read, use, disseminate,
distribute or copy this message or attachments.
If you have received this message in error, please notify the sender
immediately and delete this message.
****************************************************************************
--------------------------------------------------------------------------
This e-mail message has been scanned for Viruses and Content and cleared
by the Ministry of Health's Content and Virus Filtering Gateway
--------------------------------------------------------------------------
References
Visible links
1. http://www.ombudsman.parliament.nz/
2. mailto:[email address]
3. https://scanmail.trustwave.com/?c=15517&...
4. https://scanmail.trustwave.com/?c=15517&...
5. https://scanmail.trustwave.com/?c=15517&...
6. mailto:[email
7. https://www.health.govt.nz/about-ministr...
8. https://scanmail.trustwave.com/?c=15517&...
9. https://scanmail.trustwave.com/?c=15517&...
10. https://scanmail.trustwave.com/?c=15517&...
11. https://scanmail.trustwave.com/?c=15517&...
12. mailto:[FOI #18521 email]
13. https://scanmail.trustwave.com/?c=15517&...
hide quoted sections
From: OIA Requests
Outlook ebuacjwb.png
14K
Download
OIA Response H202201291.pdf
166K
Download
View as HTML
CV TAG recommendations for Decision to Use Novavax.pdf
157K
Download
View as HTML
Kia ora Mr Massey,
Please see attached the response to your OIA request.
Ngā mihi
OIA Services Team
[1]Ministry of Health information releases
[2]Unite against COVID-19
****************************************************************************
Statement of confidentiality: This e-mail message and any accompanying
attachments may contain information that is IN-CONFIDENCE and subject to
legal privilege.
If you are not the intended recipient, do not read, use, disseminate,
distribute or copy this message or attachments.
If you have received this message in error, please notify the sender
immediately and delete this message.
****************************************************************************
--------------------------------------------------------------------------
This e-mail message has been scanned for Viruses and Content and cleared
by the Ministry of Health's Content and Virus Filtering Gateway
--------------------------------------------------------------------------
References
Visible links
1. https://www.health.govt.nz/about-ministr...
2. https://covid19.govt.nz/
hide quoted sections
Things to do with this request
- Add an annotation (to help the requester or others)
- Download a zip file of all correspondence
Offensive? Unsuitable?
Requests for personal information and vexatious requests are not considered valid requests for Official Information (read more).
If you believe this request is not suitable, you can report it for attention by the site administrators
Report this request
Johnny Wilkinson left an annotation ()
Extremely disappointing non-answers from a fractured government that are unwilling to move as fast as they did to approve the Pfizer mRNA therapeutic vaccine.
Link to this